Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether or not rhEpo therapy causes iron deficiency later in life, and whether or not it is safe to supplement with parenteral iron. Further study of rhEPO therapy and iron status in prematurity is necessary.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0095-5108(02)00002-7 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!